Across TCGA pan-cancer cohorts, RN7SL284P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SL284P’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RN7SL284P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL284P is over-expressed in tumor.
HNSC and KIRP are the cancer types where RN7SL284P tumor–normal differential expression is most reproducible.